News

Vipoglanstat has reached the halfway point for patient recruitment in a phase 2 endometriosis trial. Gesynta Pharma said 50 per cent of the target of 190 patients have been randomised in the NOVA trial. The study is evaluating vipoglanstat, described by the company as a novel, non-hormonal, non-opioid drug candidate for the treatment of endometriosis. [...]

By Wolfgang Hackl, CEO, OncoGenomX Inc., Allschwil, Switzerland As the FemTech World Awards 2026 winners are revealed, it is a privilege to reflect on the Research Award 2026 sponsored by OncoGenomX Inc., and on the exceptional standard set by this year’s finalists. On behalf of OncoGenomX Inc., sincere thanks to every applicant and congratulations go [...]

WEC chair Sarah Owen has criticised delays over a ban on high harm cosmetic procedures, including liquid BBLs. The Women and Equalities Committee has published a letter from health minister Karin Smyth after the government missed the 18 April deadline to respond to the committee’s report on cosmetic procedures. The report, published on 18 February, [...]

Women who do not use menopausal hormone therapy have a greater risk of developing osteopenia or osteoporosis, conditions that weaken bones and can lead to fractures, disability and loss of independence, new research suggests. The retrospective cohort study included 387 postmenopausal women who underwent DXA scans between 2021 and 2025. A DXA scan is an [...]

Light exercise and less sitting may reduce pregnant women’s risk of serious blood pressure complications, according to a new study. Researchers have proposed a daily activity and sleep guide that they say was linked to a nearly 30 per cent lower risk of hypertensive disorders of pregnancy. The suggested pattern includes fewer than eight hours [...]

We are excited to reveal the winners of the third annual Femtech World Awards. The winners were announced at a virtual event this afternoon attended by shortlisted companies, along with sponsors and judges. The event welcomed guests from the UK, Europe, Asia, Africa and North America. Thank you to all 174 entries, as well as [...]

Pregnant women’s expectations about postpartum sleep may predict sleep quality after birth, outweighing prior sleep and psychiatric history, a study suggests. The findings suggest attitudes and beliefs about sleep during pregnancy could be a modifiable risk factor for postpartum sleep concerns. They also indicate that, among women expecting the poorest sleep, higher postpartum anxiety may [...]

A weight loss jab may improve fertility outcomes in women with PMOS, early findings from an ongoing clinical trial suggest. The proof-of-concept analysis found that injectable semaglutide may offer reproductive benefits while also addressing obesity and metabolic dysfunction. It is the first report to examine how injectable semaglutide may improve reproductive outcomes in women with [...]

Women's Health Week Europe 2026 has opened applications for its flagship start-up Pitches, giving women's health innovators the chance to present on the mainstage at The Emirates Stadium in London on 7-8 October. 16 finalists will be selected across two categories: Medical Devices & Therapeutics and Consumer & Tech, with the shortlisted companies receiving the [...]

A vaccine trial will test whether an mRNA jab can help stop precancerous cells developing into bowel and ovarian cancer in people with Lynch syndrome. The first stage is due to launch this summer and will assess whether the jab can train the immune system to recognise and eliminate precancerous cells before cancer develops. Around [...]